Navigation Links
MarketsandMarkets Partners With Eyeforpharma For The Pharma Forecasting Excellence Europe 2010 Summit
Date:4/23/2010

LONDON, April 23, 2010 /PRNewswire/ --

- Managing uncertainty; A Migraine For Pharma Forecasters

Forecasting in pharmaceuticals has its up's and down's, with new markets and products proving more complex and requiring sophisticated approaches to forecast these areas.

Dealing with uncertainties is no easy task. With a number of risks to consider, pharmaceutical forecasting teams need to be able to recognise commercial uncertainties surrounding a given product, capture it and manage the associated risk.

"As recent times have demonstrated the future is uncertain, but we have to make decision now." Says Nich Guthrie, Head of Forecasting - Global Marketing, AstraZeneca. "How we handle uncertainty, and not be paralysed by it, is critical to making good investment decisions".

Adopting successful risk management strategies and scenario analysis techniques can turn information into something more meaningful when tackling this challenge. Guthrie will discuss his experience and ideas on this very topic at the Pharma Forecasting Excellence summit in Zurich.

With a view to bringing key topics and innovations in forecasting to the forefront, Pharma Forecasting Excellence Europe 2010, 8-9th June, Zurich, presents best practices from pioneers in the industry.

A particular highlight will be Christian Naumann, VP Global Commercial Operations at Bayer-Schering who will be discussing their forecasting process and how to maximize the value for a global business.

    To view the full discussion visit
http://www.eyeforpharma.com/forecastingeu

MarketsandMarkets offers a specialized patient based forecast solutions for pipeline drugs across a brand's lifecycle

Forecasting plays a significant role in the pharma industry. Forecasting helps a Pharma company with opportunity analysis, resource planning & allocation, investment planning, go-no-go strategy, launch and go to market strategy. An epidemiology matrix is the back-bone of a forecast model. It takes into account prevalence, diagnosis and treatment. Epidemiology captures the impact of disease and patient dynamics; however, it is important to factor in impact of market dynamics to accurately estimate products and market potential. Capturing the impact of all market events and calibrating the forecasted model with the actual market is the appropriate way to accuracy. Calibration with the actual market scenario at every stage of forecast, including peak patient share estimation, treated patient calculation, sales calculation, etc makes the forecast more realistic and accurate.

MarketsandMarkets' patient based forecast solutions have assisted many pharma companies in their forecasting processes for pipeline and in market drugs. M&M Pharma forecasting solution is designed for phase I, II and III drugs. Forecasting has a significant impact on pricing, product launch & life cycle management, market entry strategy, manufacturing planning, sales force, promotion and planning.

    For more information visit
http://www.marketsandmarkets.com/patient-based-forecasting.asp

Meet up with the MarketsandMarkets representatives at the conference to discuss your forecasting needs!

    Media contact : EyeforPharma       Contact : MarketsandMarkets
    Puja Pankhania                     Navrose Singh Sandhu
    VP Europe                          T: +1-888-989-8004
    T: +44-(0)-207-375-7563            E: Navrose@marketsandmarkets.com
    E: Puja@eyeforpharma.com


'/>"/>
SOURCE Markets and Markets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MarketsandMarkets Partners With IIR USA for Their Event Advanced Biomarker Strategies in Oncology Drug Development
2. MarketsandMarkets Partners with the 9th Annual ePharma Summit to be Held on February 8 -10, 2010
3. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
4. MarketsandMarkets: Healthcare Information Technology Systems Market to be Worth $53.8 Billion by 2014
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):